Biochemical markers of particle induced osteolysis in C57BL/6 mice

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 11, 2010, Pages 1641-1646

  Kauther, Max D ^a   Zimmermann, Christina ^a   Bachmann, Hagen ^a   Broecker Preuss, Martina ^a   Hilken, Gero ^a   Von Knoch, Marius ^a,b   Wedemeyer, Christian ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Department of Oral and Maxillofacial Surgery   (Germany)

Author keywords

Laboratory parameters; Osteolysis; Osteolysis model; Polyethylene particles; Ultra high molecular weight polyethylene particles

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CREATININE; DEOXYPYRIDINOLINE; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ARTICLE; BONE METABOLISM; C57BL 6 MOUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; IMPLANTATION; MALE; MAMMAL; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; URINALYSIS;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; CALCIUM; MALE; MICE; MICE, INBRED C57BL; OSTEOCALCIN; OSTEOLYSIS; OSTEOPROTEGERIN; PHOSPHATES; POLYETHYLENE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RANK LIGAND; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

ANIMALIA; MAMMALIA; MUS;

EID: 78751616630     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.305     Document Type: Article

References (38)

1. Silva MJ, Sandell LJ. What's new in orthopaedic research. J Bone Joint Surg Am 2002;84-A:1490-6.
2. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res 1990;258:95-107.
3. Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997;344:33-43.
4. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, Bylski D, von Knoch F, et al. Polyethylene particle-induced bone resorption in alpha-calcitonin gene-related peptide-deficient mice. J Bone Miner Res 2007;22:1011-9.
5. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, von Knoch F, Hilken G, et al. Polyethylene particle-induced bone resorption in substance P-deficient mice. Calcif Tissue Int 2007;80:268-74.
6. von Knoch M, Jewison DE, Sibonga JD, Sprecher C, Morrey BF, Loer F, et al. The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res 2004;22:237-43.
7. Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of antitumor necrosis factor-alpha gene therapy on wear debrisinduced osteolysis. J Bone Joint Surg Am 2001;83-A:1789-97.
8. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, et al. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472-80.
9. Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFα in cell culture and murine models of aseptic loosening. Bone 2007;40:1276-83.
10. von Knoch F, Wedemeyer C, Heckelei A, Saxler G, Hilken G, Brankamp J, et al. Promotion of bone formation by simvastatin in polyethylene particle-induced osteolysis. Biomaterials 2005;26:5783-9.
11. Wedemeyer C, Xu J, Neuerburg C, Landgraeber S, Malyar NM, von Knoch F, et al. Particle-induced osteolysis in three-dimensional micro-computed tomography. Calcif Tissue Int 2007;81:394-402.
12. Chiu R, Ma T, Smith RL, Goodman SB. Ultra high molecular weight polyethylene wear debris inhibits osteoprogenitor proliferation and differentiation in vitro. J Biomed Mater Res A 2009;89:242-7.
13. Zhou X, Zhang P, Zhang C, Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. J Orthop Res 2009;12:12.
14. Streich NA, Gotterbarm T, Jung M, Schneider U, Heisel C. Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty. Int Orthop 2009;33:77-82.
15. Wang CT, Lin YT, Chiang BL, Lee SS, Hou SM. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 2009;31:77-82.
16. von Knoch M, Sprecher C, Barden B, Saxler G, Loer F, Wimmer M. [Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments]. Z Orthop Ihre Grenzgeb 2004;142:366-70.
17. Perilli E, Baruffaldi F. Proposal for shared collections of X-ray micro-CT datasets of bone specimens. ICCB03 2003:24-6.
18. Boehm O, Zur B, Koch A, Tran N, Freyenhagen R, Hartmann M, et al. Clinical chemistry reference database for Wistar rats and C57BL/6 mice. Biol Chem 2007;388:547-54.
19. Guise TA, Mundy GR. Cancer and bone. Endocr Rev 1998;19:18-54.
20. Zusman J, Brown DM, Nesbit ME. Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia. N Engl J Med 1973;289:1335-40.
21. Peach H, Compston JE, Vedi S, Horton LW. Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia. J Clin Pathol 1982;35:625-30.
22. Ralston SH, Langston AL, Reid IR. Pathogenesis and management of Paget's disease of bone. Lancet 2008;372:155-63.
23. Lumachi F, Brunello A, Roma A, Basso U. Cancer-induced hypercalcemia. Anticancer Res 2009;29:1551-5.
24. Wada S, Fukawa T, Kamiya S. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice]. Clin Calcium 2009;19:1075-82.
25. Napal J, Amado JA, Riancho JA, Olmos JM, Gonzalez-Macias J. Stress decreases the serum level of osteocalcin. Bone Miner 1993;21:113-8.
26. Takada J, Yamashita T, Takebayashi T, Nagoya S, Ishii S, Katahira G. Osteoporosis in 5 elderly women with pubic osteolysis. Acta Orthop Scand 2003;74:59-61.
27. Alexandrakis MG, Passam FH, Malliaraki N, Katachanakis C, Kyriakou DS, Margioris AN. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients. Clin Chim Acta 2002;325:51-7.
28. Spicka I, Spacek P, Hulejova H, Prochazka B, Cieslar P, Chrz M, et al. [Monitoring markers of bone turnover in multiple myeloma]. Vnitr Lek 1999;45:463-7.
29. Juraschek M, Seibel MJ, Woitge HW, Krempien B, Bauss F. Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis. Bone 2000;26:475-83.
30. Wittersheim E, Mesquita M, Demulder A, Guns M, Louis O, Melot C, et al. OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis. Clin Biochem 2006;39:617-22.
31. Granchi D, Pellacani A, Spina M, Cenni E, Savarino LM, Baldini N, et al. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J Bone Joint Surg Am 2006;88:1501-9.
32. Ulrich-Vinther M, Carmody EE, Goater JJ, Sb K, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002;84-A:1405-12.
33. Goater JJ, O'Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 2002;20:169-73.
34. Childs LM, Paschalis EP, Xing L, Dougall WC, Anderson D, Boskey AL, et al. In vivo RANK signaling blockade using the receptor activator of NF-kappaB: Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002;17:192-9.
35. Masui T, Sakano S, Hasegawa Y, Warashina H, Ishiguro N. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles. Biomaterials 2005;26:1695-702.
36. Gehrke T, Sers C, Morawietz L, Fernahl G, Neidel J, Frommelt L, et al. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol 2003;32:287-94.
37. Horiki M, Nakase T, Myoui A, Sugano N, Nishii T, Tomita T, et al. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 2004;22:346-51.
38. Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 2003;85:1196-201.